U.S. Stock News

The recent decision by the Centers for Medicare & Medicaid Services to lift 2027 Medicare Advantage payment rates has pushed Humana (HUM) sharply into focus, with the stock jumping after the policy update. See our latest analysis for Humana. That policy-driven jump has arrived after a tougher spell, with a 12.1% 7 day share price return and 11.1% 30 day share price return partly offsetting a 28.5% 90 day share price decline and a 61.4% 3 year total shareholder return loss. This suggests that...

If you are wondering whether Allstate at around US$212 per share still offers value, or if most of the opportunity is already priced in, this article breaks down what the current price might be implying. The stock has returned 3.9% over the last 7 days, 2.1% over the past month, 4.0% year to date and 12.0% over the last year, while the 3-year and 5-year returns sit at 95.6% and 98.7% respectively. Recent coverage has focused on Allstate's position within the broader insurance sector and how...

If you are wondering whether EZCORP’s share price still offers value after a strong run, the next sections break down what the current market price might be implying about the business. EZCORP most recently closed at US$28.03, with reported returns of 7.7% over the past week, 5.0% over the last month, 39.7% year to date, 85.3% over 1 year, 213.2% over 3 years and a very large gain over 5 years. Recent price moves sit alongside ongoing interest in EZCORP’s role in consumer finance and its...

Wondering if Sempra at around US$98.88 is offering value or asking too much, especially after such a strong run? This article breaks down what the current price could mean for you. Over the short term, Sempra has posted returns of 1.5% over 7 days, 5.7% over 30 days, 10.2% year to date, 49.7% over 1 year, 41.3% over 3 years, and 71.0% over 5 years. This naturally raises questions about how much optimism is already reflected in the share price. Recent coverage has focused on Sempra's position...

Hercules Capital (HTGC) has drawn fresh attention after reporting a record US$1.81b in new debt and equity commitments for Q1 2026, while simultaneously confronting multiple securities class action lawsuits. See our latest analysis for Hercules Capital. At a share price of US$14.98, Hercules Capital has seen a 2.9% 7 day share price return and a 20.6% year to date share price decline, while the 3 year total shareholder return of 67.0% points to a much stronger longer term outcome, with recent...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Celebrations may be in order for APA Corporation ( NASDAQ:APA ) shareholders, with the analysts delivering a...

We wouldn't blame Willis Lease Finance Corporation ( NASDAQ:WLFC ) shareholders if they were a little worried about the...

Even though Lexeo Therapeutics, Inc. ( NASDAQ:LXEO ) stock gained 14% last week, insiders who sold US$381k worth of...

Some Semtech Corporation ( NASDAQ:SMTC ) shareholders may be a little concerned to see that the Executive VP & Chief...

Aerie owner American Eagle Outfitters (AEO) is back in focus after a new campaign featuring Pamela Anderson, which highlights a pledge to avoid AI generated and retouched bodies in its advertising. See our latest analysis for American Eagle Outfitters. The campaign lands at a time when the share price is US$18.31, with a 1 day share price return of 5.47% and a 7 day return of 5.72%, but a 90 day share price decline of 34.02%, while the 1 year total shareholder return of 68.59% contrasts with...

Key recent moves in Apellis Pharmaceuticals (APLS) Apellis Pharmaceuticals (APLS) has drawn investor attention after a sharp move in its share price over the past month, with the stock returning about 104% over that period. See our latest analysis for Apellis Pharmaceuticals. That sharp 103.6% 30 day share price return sits on top of a 54.9% 90 day gain and a 57.4% year to date move. The 1 year total shareholder return of 107.5% contrasts with weaker 3 year and 5 year total shareholder...

If you are wondering whether Palo Alto Networks' share price reflects its underlying worth, this article breaks down what current numbers can and cannot tell you about value. Recently, the stock closed at US$173.78, with returns of 8.2% over 7 days, 5.3% over 30 days, 0.4% over 1 year, 78.0% over 3 years and 188.8% over 5 years, which may influence how you think about both opportunity and risk. Alongside these moves, investors have been reacting to ongoing news around cybersecurity demand,...

Spire Global (SPIR) has drawn fresh attention after rolling out an expanded agriculture intelligence platform that fuses 40 years of soil moisture data with daily satellite readings, extended forecasts, and AI driven seasonal guidance. See our latest analysis for Spire Global. The latest agriculture platform launch comes after a busy few weeks that included a ten satellite mission supporting projects in quantum sensing, optical inter satellite links, Earth observation, and IoT connectivity,...

Green railcar financing sets the tone for Trinity Industries stock Trinity Industries (TRN) has drawn fresh attention after subsidiaries arranged a $480.8 million secured green railcar note issuance backed by about 15,082 leased railcars, spotlighting the company’s capital markets and ESG focused financing approach. See our latest analysis for Trinity Industries. The green railcar securitization news arrives as Trinity Industries’ share price trades at $33.42, with a 1-day share price return...

NIO (NYSE:NIO) has revealed its ES9 flagship SUV, described as its largest and most advanced vehicle to date. The company is rolling out new smart driving and high end technology features for the ES9 and upcoming models. Onvo, NIO’s sub brand, is shifting from Nvidia chips to in house Shenji smart driving chips, starting with the L90. NIO shares currently trade at $6.38, with the stock up 29.1% over the past month and 24.1% year to date. Over the past year, NYSE:NIO has returned 92.7%,...

Wondering if Cushman & Wakefield at around US$13.54 is offering fair value or a potential mispricing opportunity? This article walks through the key signals behind the current price. The stock has returned 8.3% over the last 7 days and 6.0% over the last 30 days. It sits on a 14.5% year to date decline, yet shows a 57.8% return over 1 year and 41.3% over 3 years, with a 19.5% decline over 5 years. Recent attention around Cushman & Wakefield has centered on its role as a major global real...

If you are wondering whether Itron at around US$92.99 is offering good value today, you are not alone in asking what the current share price really reflects. The stock has recently shown a mixed return pattern, with a 2.8% gain over the past week, a 3.3% decline over the past month, and a 1.6% decline year to date, while the 1 year return sits at a 6.6% loss and the 3 year return at 73.8%. Recent coverage around Itron has focused on its role in power grid technology and smart infrastructure...

The U.S.-Iran ceasefire has shifted sentiment for travel related stocks, and Airbnb (ABNB) quickly moved higher as investors weighed lower crude prices, reduced geopolitical risk, and existing expectations for solid earnings and revenue growth. See our latest analysis for Airbnb. At a share price of $131.40, Airbnb has seen a 1-day share price return of 5.15% and a 7-day share price return of 4.96%. Its 1-year total shareholder return of 8.31% contrasts with weaker 3 month share price...

In recent weeks, Arista Networks has drawn attention after several analysts upgraded the stock and highlighted its growing role in AI-focused data center networking, alongside the launch of liquid-cooled, high-density optics modules for large-scale GPU clusters. An interesting angle is how this wave of analyst optimism is rooted not just in AI demand, but in Arista’s push into advanced Ethernet-based optics that could reshape how hyperscalers build and scale their networks. Next, we’ll...

Analyst coverage from Zacks has put fresh attention on DiamondRock Hospitality (DRH), as the firm reiterates a favorable earnings outlook and Buy ranking, highlighting earnings estimate revisions and valuation metrics versus hotel focused REIT peers. See our latest analysis for DiamondRock Hospitality. The latest Zacks commentary comes as DiamondRock Hospitality’s share price sits at US$9.76, with a 90 day share price return of 6.55% and a 1 year total shareholder return of 39.96%. This may...

Cigna Group, NYSE:CI, is reporting steady revenue growth alongside a significant decline in its customer base over the past two years. This combination suggests product and competitive pressures that are starting to reshape how the company earns its revenue. The shift in customer numbers is becoming a key issue for investors tracking Cigna's long term position in health benefits and related services. Cigna Group, NYSE:CI, recently closed at $277.56, with the share price up 3.8% over the...

Wondering if American Express at around US$316 per share is still offering value or if the easy gains are behind it? This breakdown is designed to help you weigh that up with a clear focus on price versus fundamentals. The stock has returned 4.9% over the last 7 days and 3.6% over the last 30 days, while the year-to-date return is a 15.1% decline, compared with a 21.8% return over the last year and 105.8% and 128.0% over the last 3 and 5 years respectively. Recent attention on American...

FDA review extension puts spotlight on Travere Therapeutics The latest move in Travere Therapeutics (TVTX) comes after the FDA extended its review of the supplemental New Drug Application for Filspari. The agency set a new April 2026 action date that reshapes the timeline investors are watching. See our latest analysis for Travere Therapeutics. Travere’s share price has reacted quickly to the FDA update, with a recent 9.5% jump and a 10.65% 1 month share price return. However, the year to...